Your PlexusDx report provides educational, personalized insights related to genetic predispositionssuch as genes tied to appetite regulation (FTO), insulin sensitivity (TCF7L2), and calcium/vitamin D transport (GC)to help explain why nutrient timing and nutrient density may matter for long-term success while using GLP-1 therapy
It simultaneously activates two receptor pathways that regulate blood sugar, appetite, and energy metabolism
Wegovy, a leading injected form of semaglutide, offers a weekly treatment using a straightforward pen device
Patients with specific FTO and MC4R variants may demonstrate enhanced appetite suppression and greater weight lossdirectly translating to more substantial blood pressure reductions
The overall risk of NAION remains low, and for most patients, the cardiovascular and metabolic benefits of these medications continue to outweigh the risk
Vita Bella offers guided, clinically supported programs to help you achieve optimal